Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases
基于合并症的接受恩扎卢胺和阿比特龙治疗的转移性去势抵抗性前列腺癌退伍军人的生存率
期刊:Prostate Cancer and Prostatic Diseases
影响因子:5.8
doi:10.1038/s41391-022-00588-5
Schoen, Martin W; Carson, Kenneth R; Eisen, Seth A; Bennett, Charles L; Luo, Suhong; Reimers, Melissa A; Knoche, Eric M; Whitmer, Alison L; Yan, Yan; Drake, Bettina F; Sanfilippo, Kristen M